Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.20.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Income Statement [Abstract]    
Revenue $ 121 $ 257
Operating expenses:    
Research and development 38,394 21,560
Selling, general and administrative 10,648 8,680
Total operating expenses 49,042 30,240
Loss from operations (48,921) (29,983)
Other expense (income):    
Loss on extinguishment of debt 1,045 0
Amortization of debt issuance costs and discount 1,171 428
Interest income (805) (967)
Interest expense 986 1,626
Other income (538) 0
Warrant liabilities fair value adjustment 4,497 (11,866)
Derivative liability fair value adjustment (1,567) 0
Total other expense (income): 4,789 (10,779)
Loss before taxes (53,710) (19,204)
Income tax benefit 0 6,736
Net loss $ (53,710) $ (12,468)
Net loss per share – basic and diluted $ (0.96) $ (0.28)
Weighted average common shares outstanding – basic and diluted 56,081,384 43,883,995